Invention Grant
- Patent Title: VEGF antagonist formulations
- Patent Title (中): VEGF拮抗剂制剂
-
Application No.: US12835065Application Date: 2010-07-13
-
Publication No.: US08110546B2Publication Date: 2012-02-07
- Inventor: Daniel Dix , Kelly Frye , Susan Kautz
- Applicant: Daniel Dix , Kelly Frye , Susan Kautz
- Applicant Address: US NY Tarrytown
- Assignee: Regeneron Pharmaceuticals, Inc.
- Current Assignee: Regeneron Pharmaceuticals, Inc.
- Current Assignee Address: US NY Tarrytown
- Agency: Regeneron Pharmaceuticals, Inc.
- Agent Joseph E. Zahner
- Main IPC: A61K38/18
- IPC: A61K38/18 ; A61K39/00 ; C12P21/02 ; C07H21/04
Abstract:
Formulations of a vascular endothelial growth factor (VEGF)-specific fusion protein antagonist are provided including a pre-lyophilized formulation, a reconstituted lyophilized formulation, and a stable liquid formulation. Preferably, the fusion protein has the sequence of SEQ ID NO:4.
Public/Granted literature
- US20100279933A1 VEGF ANTAGONIST FORMULATIONS Public/Granted day:2010-11-04
Information query
IPC分类:
